back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2015-11-24 Tx date 2015-11-20 |
$VRX
Valeant Pharmaceuticals International, Inc. |
JORN, DEBORA
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-240,331
-2,641 vol $91.00 each |
27,884 | |
| Filed 2015-11-24 Tx date 2015-11-20 |
$VRX
Valeant Pharmaceuticals International, Inc. |
JORN, DEBORA
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$240,331
+2,641 vol $91.00 each |
8,298 | |
| Filed 2015-11-24 Tx date 2015-11-20 |
$VRX
Valeant Pharmaceuticals International, Inc. |
JORN, DEBORA
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-124,670
-1,370 vol $91.00 each |
6,928 | |
| Filed 2015-11-24 Tx date 2015-05-20 |
$VRX
Valeant Pharmaceuticals International, Inc. |
JORN, DEBORA
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-11-24 Tx date 2015-05-20 |
$VRX
Valeant Pharmaceuticals International, Inc. |
JORN, DEBORA
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
30,525 | ||
| Filed 2015-05-29 Tx date 2015-05-20 |
$VRX
Valeant Pharmaceuticals International, Inc. |
JORN, DEBORA
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
11,734 | ||
| Filed 2015-05-29 Tx date 2015-05-20 |
$VRX
Valeant Pharmaceuticals International, Inc. |
JORN, DEBORA
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
8,756 | ||
| Filed 2015-05-29 Tx date 2015-05-20 |
$VRX
Valeant Pharmaceuticals International, Inc. |
JORN, DEBORA
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
7,925 | ||
| Filed 2015-05-29 Tx date 2015-05-20 |
$VRX
Valeant Pharmaceuticals International, Inc. |
JORN, DEBORA
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
5,657 |